New $3.2 billion program will support the development of drug to treat Covid-19
The New York Times reports: The U.S. government spent more than $18 billion last year funding drugmakers to make a Covid vaccine, an effort that led to at least five highly effective shots in record time. Now it’s pouring more than $3 billion on a neglected area of research: developing pills to fight the virus early in the course of infection, potentially saving many lives in the years to come. The new program, announced on Thursday by the Department of…